Executive Dysfunction Clinical Trial
— TRASOfficial title:
Causal Role of the Aperiodic Signal for Working Memory
Working memory (WM) is the ability to hold relevant information in mind in the absence of sensory input. The capacity for WM is a foundation for cognitive control and higher cognitive function more broadly. Previous research demonstrated that during the delay period of WM tasks, oscillatory electrical activity in the prefrontal cortex in the theta-frequency band (4-8 Hz) increased in amplitude. However, other groups found that the slope of the aperiodic signal in the brain was positively correlated with individual differences in WM capacity. Since low-frequency power and a steeper slope of the aperiodic signal are confounded in many analyses, it is not clear whether the slope of the aperiodic signal or the amplitude of low-frequency oscillations underlie WM capacity. With many studies investigating the causal role of theta oscillations in WM, the purpose of this project is to investigate the role of the aperiodic signal in WM performance.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | December 2024 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Between the ages of 18 and 35 - Able to provide informed consent - Normal or corrected-to-normal vision - Willing to comply with all study procedures and be available for the duration of the study - Ability to speak, read and understand English without a translator - Not color-blind Exclusion Criteria: - ADHD/ADD (currently under treatment) - Neurological disorder and conditions - Medical or neurological illness or treatment for a medical disorder that could interfere with study participation, e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment - Prior brain surgery - Any brain devices/implants, including cochlear implants and aneurysm clips - History of traumatic brain injury - (For females) Pregnant - Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study - Current use of medications know to produce specific EEG activity known to disrupt interpretations of the findings including but not limited to: benzodiazepines, antipsychotics, antiepileptics and central nervous system stimulants |
Country | Name | City | State |
---|---|---|---|
United States | Florida State University | Tallahassee | Florida |
Lead Sponsor | Collaborator |
---|---|
Florida State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in number of remembered items | The number of remembered items, often referred to as working memory capacity, is calculated as the number of items to be remembered multiplied by the number of items successfully remembered divided by the number of total trials. The range of values is 0 to 7 where a larger number denotes a greater number of items that were remembered. | 3 hours | |
Secondary | Change in slope of the power spectrum of the EEG | The power spectrum of an electrical brain recording is calculated by performing a Fourier transform on the time signal. The slope is calculated as the general trend of this background signal. | 3 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04111549 -
GOALS Cognitive Training Delivered to Aging Veterans in Person or Via Telehealth
|
N/A | |
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Enrolling by invitation |
NCT05017779 -
A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth
|
N/A | |
Terminated |
NCT02416193 -
Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)
|
Phase 2 | |
Recruiting |
NCT06073717 -
Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT).
|
N/A | |
Completed |
NCT02613936 -
Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT05874791 -
Executive Control Training for Adolescents With ADHD: A Randomized Controlled Effectiveness Trial
|
N/A | |
Recruiting |
NCT04465708 -
HOPS Study: A Conceptual Replication
|
N/A | |
Active, not recruiting |
NCT05131659 -
Intervention-Induced Plasticity of Flexibility and Learning Mechanisms in ASD
|
N/A | |
Active, not recruiting |
NCT04121650 -
Executive Function and Symptom Reduction in Youth Receiving Home-based Treatment With Collaborative Problem Solving
|
||
Completed |
NCT04221841 -
Executive Functions and Reinforcement Sensitivity in Women With Obsessive Compulsive Symptoms
|
||
Completed |
NCT03285347 -
Effect of Computer-based Cognitive Training on Attention and Executive Functions in Patients With Parkinson's Disease
|
N/A | |
Completed |
NCT03490110 -
Brain Markers of Improvements in Cognitive Functioning
|
N/A | |
Completed |
NCT03073122 -
The Boston Circulatory Arrest Study: Antecedents and Correlates of Well-Being in Adults With Congenital Heart Disease
|
||
Completed |
NCT03958487 -
An Executive/Monitoring Treatment Protocol on Everyday Life Activities
|
N/A | |
Completed |
NCT02091284 -
Bilateral Prefrontal Modulation in Alcoholism
|
N/A | |
Completed |
NCT02091167 -
Bilateral Prefrontal Modulation in Crack-cocaine Addiction
|
Phase 2 | |
Completed |
NCT01730261 -
Online Emotional Regulation Group Treatment
|
Phase 1 | |
Completed |
NCT00271596 -
Citalopram to Enhance Cognition in HD
|
Phase 2 | |
Active, not recruiting |
NCT04108728 -
Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )
|
N/A |